文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

重症COVID-19或流感病毒肺炎患者疱疹病毒科肺部再激活与感染:一项比较研究

Herpesviridae lung reactivation and infection in patients with severe COVID-19 or influenza virus pneumonia: a comparative study.
PubMed 文献 · Ann Intensive Care · 2022-09-24
一句话结论重症COVID-19患者HSV和CMV肺部再激活常见,但不比重症流感患者更频繁,且未检测到对结局的影响。

该回顾性单中心队列研究纳入145例需有创机械通气的重症COVID-19肺炎患者,因怀疑呼吸机相关性肺炎行纤维支气管镜肺泡灌洗检测HSV和CMV,并与89例需有创机械通气的重症流感肺炎历史队列比较。COVID-19组HSV和CMV肺部再激活率分别为50%和42%,流感组分别为63%和28%。考虑拔管和死亡为竞争事件后,流感组HSV肺部再激活累积发生率高于COVID-19组(p=0.03),而HSV支气管肺炎发生率两组相似(31%和25%);CMV肺部再激活累积发生率两组相似(p=0.07)。无论COVID-19、流感或全部患者分组,合并HSV或CMV肺部再激活的患者结局与无再激活者相似。

要点

  • 重症COVID-19需有创机械通气患者中,HSV和CMV肺部再激活率分别为50%和42%。
  • 重症流感需有创机械通气患者中,HSV和CMV肺部再激活率分别为63%和28%。
  • 考虑拔管和死亡为竞争事件后,流感组HSV肺部再激活累积发生率高于COVID-19组(p=0.03)。
  • HSV支气管肺炎发生率COVID-19组31%、流感组25%,两组相似。
  • 考虑拔管和死亡为竞争事件后,CMV肺部再激活累积发生率两组相似(p=0.07)。

适用人群与场景

  • 145例重症COVID-19肺炎需有创机械通气、因怀疑呼吸机相关性肺炎行纤维支气管镜肺泡灌洗检测HSV和CMV的患者。
  • 历史对照为89例重症流感肺炎需有创机械通气的患者。

研究设计与关键结果

  • 研究类型:回顾性单中心队列研究,145例COVID-19患者与89例流感历史队列比较。
  • COVID-19组HSV和CMV肺部再激活率分别为50%和42%;流感组分别为63%和28%。
  • 考虑拔管和死亡为竞争事件后,HSV肺部再激活累积发生率流感组高于COVID-19组(p=0.03)。
  • HSV支气管肺炎发生率COVID-19组31%、流感组25%,两组相似。
  • 考虑拔管和死亡为竞争事件后,CMV肺部再激活累积发生率COVID-19组与流感组相似(p=0.07)。
  • 无论COVID-19患者、流感患者或全部患者分组,合并HSV或CMV肺部再激活的患者结局与无再激活者相似。

证据类型、等级与局限

  • 证据类型:回顾性单中心队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,尽管未检测到HSV和CMV肺部再激活对结局的影响,抗病毒治疗对这些疱疹病毒科再激活的效果在这些患者中仍有待确定。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Lung reactivations of Herpesviridae, herpes simplex virus (HSV) and cytomegalovirus (CMV) have been reported in COVID-19 patients. Whether or not those viral reactivations are more frequent than in other patients is not known.

METHODS: Retrospective monocentric cohort study of 145 patients with severe COVID-19 pneumonia requiring invasive mechanical ventilation and who were tested for HSV and CMV in bronchoalveolar lavage performed during fiberoptic bronchoscopy for ventilator-associated pneumonia suspicion. Rates of HSV and CMV lung reactivations, and HSV bronchopneumonitis were assessed and compared with an historical cohort of 89 patients with severe influenza pneumonia requiring invasive mechanical ventilation.

RESULTS: Among the 145 COVID-19 patients included, 50% and 42% had HSV and CMV lung reactivations, respectively, whereas among the 89 influenza patients, 63% and 28% had HSV and CMV lung reactivations, respectively. Cumulative incidence of HSV lung reactivation (taking into account extubation and death as competing events) was higher in influenza than in COVID-19 patients (p = 0.03), whereas the rate of HSV bronchopneumonitis was similar in both groups (31% and 25%, respectively). Cumulative incidence of CMV lung reactivation (taking into account extubation and death as competing events) was similar in COVID-19 and influenza patients (p = 0.07). Outcomes of patients with HSV or CMV lung reactivations were similar to that of patients without, whatever the underlying conditions, i.e., in COVID-19 patients, in influenza patients, or when all patients were grouped.

CONCLUSIONS: HSV and CMV lung reactivations are frequent in COVID-19 patients, but not more frequent than in patients with influenza-associated severe pneumonia, despite a higher severity of illness at intensive care unit admission of the latter and a longer duration of mechanical ventilation of the former. Although no impact on outcome of HSV and CMV lung reactivations was detected, the effect of antiviral treatment against these Herpesviridae remains to be determined in these patients.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Luyt CE, Burrel S, Mokrani D, et al. Herpesviridae lung reactivation and infection in patients with severe COVID-19 or influenza virus pneumonia: a comparative study. Ann Intensive Care. 2022. PMID: 36153427. doi:10.1186/s13613-022-01062-0

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。